VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHCNational HealthCare Corporation
$206.54$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNHCQuarterly Financials

National HealthCare Corporation (NHC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

National HealthCare Corporation (NHC) quarterly income statement — complete revenue, gross profit & net income history

NHC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue380.04M386.51M382.66M374.91M373.7M369.35M340.2M291.21M297.18M300.91M288.49M282.58M
Revenue Growth %1.7%4.65%12.48%28.74%25.75%22.74%17.93%3.05%10.24%13.97%6.51%4.26%
Cost of Goods Sold264.1M233.24M233.18M226.53M228.13M234.32M213.4M180.08M183.14M186.56M182.66M175.29M
COGS % of Revenue69.49%60.34%60.94%60.42%61.05%63.44%62.73%61.84%61.63%62%63.32%62.03%
Gross Profit115.94M153.27M149.49M148.38M145.57M135.03M126.8M111.14M114.04M114.35M105.82M107.29M
Gross Margin %30.51%39.66%39.06%39.58%38.95%36.56%37.27%38.16%38.37%38%36.68%37.97%
Gross Profit Growth %-20.36%13.51%17.89%33.51%27.65%18.08%19.83%3.59%12.09%18.26%8.37%11.64%
Operating Expenses220.23M120.16M119.11M114.29M114.8M108.47M105.76M88.62M98.41M94.23M92.8M93.31M
OpEx % of Revenue57.95%31.09%31.13%30.48%30.72%29.37%31.09%30.43%33.11%31.32%32.17%33.02%
Selling, General & Admin012.19M11.35M11.33M11.37M31.8M10.89M10.57M10.35M11.44M10.09M9.9M
SG&A % of Revenue-3.15%2.96%3.02%3.04%8.61%3.2%3.63%3.48%3.8%3.5%3.5%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income-104.29M33.12M30.38M34.09M30.77M26.56M21.05M22.52M15.63M20.12M13.03M13.98M
Operating Margin %-27.44%8.57%7.94%9.09%8.23%7.19%6.19%7.73%5.26%6.69%4.52%4.95%
Operating Income Growth %-438.98%24.67%44.33%51.38%96.86%32.03%61.59%61.12%56.1%122.32%219.4%207.12%
EBITDA-92.68M44.89M41.54M45.1M41.74M38.01M31.67M31.86M26.21M31.89M23.16M24.06M
EBITDA Margin %-24.39%11.61%10.85%12.03%11.17%10.29%9.31%10.94%8.82%10.6%8.03%8.51%
EBITDA Growth %-322.01%18.1%31.17%41.58%59.24%19.19%36.73%32.41%30.68%63.29%61.61%65.34%
D&A (Non-Cash Add-back)11.61M11.77M11.16M11.02M10.98M11.44M10.62M9.34M10.59M11.77M10.13M10.08M
EBIT45.08M32.95M55.87M34.16M45.83M8.4M59.78M36.6M35.76M36.72M14.11M22.42M
Net Interest Income1.92M1.64M1.22M2.59M19K-33K861K2.65M2.49M2.76M2.15M1.7M
Interest Income2.19M2.46M2.68M2.59M2.13M2.31M2.6M2.65M2.54M2.81M2.22M1.79M
Interest Expense269K816K1.46M02.11M2.35M1.74M046K56K77K93K
Other Income/Expense149.11M-984K24.03M-1.92M12.96M-20.51M36.99M14.08M20.08M16.55M1M8.35M
Pretax Income44.81M32.13M54.41M32.17M43.72M6.06M58.04M36.6M35.71M36.66M14.03M22.32M
Pretax Margin %11.79%8.31%14.22%8.58%11.7%1.64%17.06%12.57%12.02%12.18%4.86%7.9%
Income Tax8.71M6.94M13.4M8.05M11.43M28K15.34M9.49M9.46M8.7M3.91M6.41M
Effective Tax Rate %19.44%21.59%24.63%25.04%26.15%0.46%26.43%25.94%26.49%23.73%27.86%28.7%
Net Income35.86M24.85M39.24M23.72M32.2M6.08M42.79M26.84M26.21M28.41M10.39M16.28M
Net Margin %9.44%6.43%10.25%6.33%8.62%1.65%12.58%9.22%8.82%9.44%3.6%5.76%
Net Income Growth %11.34%308.63%-8.3%-11.63%22.86%-78.59%311.91%64.88%123.6%347.13%527.67%408.3%
Net Income (Continuing)36.1M25.19M41.01M24.11M32.29M6.03M42.7M27.11M26.25M27.96M10.12M15.92M
Discontinued Operations000000000000
Minority Interest5.67M5.74M5.25M3.48M3.09M3M3.33M2.03M1.77M1.73M2.17M2.44M
EPS (Diluted)2.271.582.501.522.070.392.731.731.691.830.681.06
EPS Growth %9.66%305.13%-8.42%-12.14%22.49%-78.69%301.47%63.21%122.37%346.34%525%657.14%
EPS (Basic)2.311.612.531.532.090.392.781.741.711.860.681.06
Diluted Shares Outstanding15.77M15.65M15.66M15.6M15.58M15.67M15.67M15.56M15.51M15.49M15.32M15.32M
Basic Shares Outstanding15.54M15.47M15.48M15.46M15.44M15.42M15.41M15.39M15.35M15.31M15.3M15.3M
Dividend Payout Ratio-39.97%25.28%39.77%29.25%154.89%21.99%33.85%34.53%31.82%87.01%53.64%